Related references
Note: Only part of the references are listed.Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe
Fanni Rencz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity
F. Rencz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
Wei Zhang et al.
PHARMACOECONOMICS (2015)
Inequities in access to biologic and synthetic DMARDs across 46 European countries
Polina Putrik et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The economic burden of psoriasis: a systematic literature review
Steven R. Feldman et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2014)
Disease burden of psoriasis associated with psoriatic arthritis in Hungary
Rencz Fanni et al.
ORVOSI HETILAP (2014)
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
Laszlo Gulacsi et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
Marta Pentek et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
Valentin Brodszky et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
Orsolya Balogh et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
Emese Heredi et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
Laszlo Gulacsi et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Economical aspect of biological therapy in inflammatory conditions in Hungary
Judit Laki et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies
A. D. Ormerod et al.
DERMATOLOGY (2012)
Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens
R. Gniadecki et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U. Mrowietz et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)
PSY46 INDIRECT COSTS OF MODERATE AND SEVERE FORMS OF PSORIASIS IN CZECH REPUBLIC: CALCULATION BASED ON SELF REPORTED QUESTIONNAIRE
J Klimes et al.
VALUE IN HEALTH (2011)
TREATMENT OF PATIENTS WITH MODERATE AND SEVERE PSORIASIS - COST-OF-ILLNESS IN THE CZECH REPUBLIC
A. Petrikova et al.
VALUE IN HEALTH (2011)
Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis
Kristian Reich et al.
DERMATOLOGY (2009)
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis
T. A. Luger et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
European S3-Guidelines on the systemic treatment of psoriasis vulgaris
D. Pathirana et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
D. Revicki et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial
Richard Shikiar et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
Richard Shikiar et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Quality of life in patients with psoriasis: A systematic literature review
J de Korte et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Share Paper
